Processa Pharmaceuticals, Inc. (PCSA) Operating cash flow 2016–2025
Processa Pharmaceuticals, Inc. (PCSA) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
-$11.4MFY2025 · since FY2016: -$2.2M → -$11.4M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$11.4M | -1.2% |
| FY2024 | -$11.2M | -39.5% |
| FY2023 | -$8.1M | +16.1% |
| FY2022 | -$9.6M | -10.2% |
| FY2021 | -$8.7M | -177.3% |
| FY2020 | -$3.1M | -14.3% |
| FY2019 | -$2.8M | +25.8% |
| FY2018 | -$3.7M | -124.1% |
| FY2017 | -$1.7M | +23.2% |
| FY2016 | -$2.2M | — |
Source: SEC XBRL filings · For reference only · Not investment advice